GE Healthcare has received the US Food and Drug Administration 510(k) approval for its new computed tomography (CT) technology - Veo.
The new CT technology aids physicians to deliver accurate diagnoses by enabling CT image clarity at lower dose.
Veo is a dose-optimizing technology which utilizes Model-based Iterative Reconstruction (MBIR) technique, and is available on GE Discovery CT750 HD systems in Europe, Canada and regions of Asia.
University Hospital Radiology Department chair Johan Mey said with a clinical chest CT at 0.05 mSv, they produced images where they could see and analyze pathology.
"With Veo, we can conduct lower dose CT scans in children, too, and this is particularly important in groups that require continued follow-up, such as those with cystic fibrosis or lymphoma," Mey said.